Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Michele Malagola, Nicola Polverelli, Massimo Martino, Vicky Rubini, Maria Teresa Lupo Stanghellini, Francesca Patriarca, Renato Fanin, Benedetto Bruno, Luisa Giaccone, Danilo Giuseppe Faraci, Giovanni Grillo, Stefania Bramanti, Luca Castagna, Paolo Bernasconi, Anna Amelia Colombo, Marco De Gobbi, Paolo Nicoli, Annalisa Natale, Stella Santarone, Elisabetta Terruzzi, Attilio Olivieri, Ilaria Scortechini, Patrizia Chiusolo, Elisabetta Metafuni, Angelo Michele Carella, Emanuela Merla, Marco Casini, Irene M Cavattoni, Mario Arpinati, Chiara Nozzoli, Ilaria Cutini, Patrizio Mazza, Annamaria Mazzone, Simona Bassi, Francesco Onida, Giorgia Saporiti, Filippo Antonio Canale, Adriana Vacca, Eugenia Piras, Piero Galieni, Sadia Falcioni, Mario Luppi, Giulia Debbia, Anna Paola Iori, Ursula La Rocca, Vincenzo Pavone, Anna Mele, Cristina Skert, Francesca Carobolante, Paola Carluccio, Carlo Borghero, Francesca Elice, Anna Proia, Fulvia Fanelli, Carmine Selleri, Nicoletta Sacchi, Sonia Mammoliti, Elena Oldani, Fabio Ciceri, Francesca Bonifazi, Domenico Russo

Blood (2021) 138 (Supplement 1): 1786.

https://doi.org/10.1182/blood-2021-145970

Published: 2021

Journal Articles

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Paola Tacchetti, MD, Lucia Pantani, MD, Valerio De Stefano, MD, Elena Zamagni, MD, Jacopo Peccatori, MD, Annalisa Pezzi, Statistician, Catello Califano, MD, Andrea Nozza, MD, Patrizia Tosi, MD, Carolina Terragna, PhD, Fabrizio Ciambelli, MD, Delia Cangini, MD, Piero Galieni, MD, Clotilde Cangialosi, MD, Giovanni De Sabbata, MD, Francesca Elice, MD, Antonio Palumbo, MD, Michele Cavo, MD

Blood (2014) 124 (21): 196.

https://doi.org/10.1182/blood.V124.21.196.196

Published: 2014

Journal Articles

Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)

Blood (2011) 118 (21): 1821.

https://doi.org/10.1182/blood.V118.21.1821.1821

Published: 2011

Journal Articles

Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients

Blood (2010) 116 (21): 3029.

https://doi.org/10.1182/blood.V116.21.3029.3029

Published: 2010

Journal Articles

MPT Vs ThaDD in Very Elderly Patients with Multiple Myeloma: a Case-Match Study.

Blood (2009) 114 (22): 1835.

https://doi.org/10.1182/blood.V114.22.1835.1835

Published: 2009

Journal Articles

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Blood (2009) 114 (22): 492.

https://doi.org/10.1182/blood.V114.22.492.492

Published: 2009

Journal Articles

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Roberto Cairoli, Alessandro Beghini, Giovanni Grillo, Gianpaolo Nadali, Francesca Elice, Carla Barbara Ripamonti, Patrizia Colapietro, Michele Nichelatti, Laura Pezzetti, Monia Lunghi, Antonio Cuneo, Assunta Viola, Felicetto Ferrara, Mario Lazzarino, Francesco Rodeghiero, Giovanni Pizzolo, Lidia Larizza, Enrica Morra

Blood (2006) 107 (9): 3463–3468.

https://doi.org/10.1182/blood-2005-09-3640

Published: 2006

Journal Articles

Serum Concentrations of Vitamin B-12 and Alkaline Phosphatase in Newly Diagnosed Multiple Myeloma Patients.

Francesca Elice, MD, Maurizio Zangari, MD, Bart Barlogie, MD, Michael J. Burns, BS, Guido J. Tricot, MD, PhD, Sara Roberti, MD, Francesco Rodeghiero, MD, R. Jean Hine, PhD

Blood (2005) 106 (11): 5110.

https://doi.org/10.1182/blood.V106.11.5110.5110

Published: 2005

Journal Articles

Acquired Resistance to Activated Protein C (aAPCR) Is Associated with Increased Risk of Deep Vein Thrombosis in Multiple Myeloma.

Francesca Elice, MD, Louis Fink, MD, Guido J. Tricot, MD, PhD, Teresa J. Milner, BS, Bart Barlogie, MD, PhD, Maurizio Zangari, MD

Blood (2005) 106 (11): 3484.

https://doi.org/10.1182/blood.V106.11.3484.3484

Published: 2005

Journal Articles

The Anti-Myeloma Effect of Bortezomib Is Associated with Osteoblastic Activity.

Maurizio Zangari, MD, Kevin B. Najarian, MS, Dixie L. Esseltine, MD, Choon-Kee Lee, MD, Bart Barlogie, MD, PhD, Francesca Elice, MD, Michael J. Burns, BS, BA, Shmuel Yaccoby, PhD, Paul Richardson, MD, Pieter Sonneveld, MD

Blood (2005) 106 (11): 510.

https://doi.org/10.1182/blood.V106.11.510.510

Published: 2005

Journal Articles

Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.

Maurizio Zangari, MD, Bart Barlogie, MD, PhD, Michael J. Burns, BS, BA, Vanessa Bolejack, MPH, Klaus A. Hollmig, MD, Frits van Rhee, MD, PhD, Mauricio Pineda-Roman, MD, Francesca Elice, MD, Guido J. Tricot, MD, PhD

Blood (2005) 106 (11): 2552.

https://doi.org/10.1182/blood.V106.11.2552.2552

Published: 2005

Journal Articles

Prognostic Impact of C-Kit Mutations in Core Binding Factor-Leukemia.

Roberto Cairoli, MD, Alessandro Beghini, PhD, Gianpaolo Nadali, MD, Francesca Elice, MD, Maria Lunghi, MD, Antonio Cuneo, MD, Giovanni Grillo, MD, Michele Nichelatti, MSc, Carla B. Ripamonti, MD, Mario Lazzarino, MD, Francesco Rodeghiero, MD, Giovanni Pizzolo, MD, Lidia Larizza, MD, Enrica Morra, MD

Blood (2004) 104 (11): 2013.

https://doi.org/10.1182/blood.V104.11.2013.2013

Published: 2004

NARROW

Overall Survival Improvement Following ALLO-SCT in Patients Older THAN 60 YEARS: A Gruppo Italiano Trapianto DI Midollo Osseo (GITMO) Registry Study

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)

Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients

MPT Vs ThaDD in Very Elderly Patients with Multiple Myeloma: a Case-Match Study.

A Phase III Study of Enoxaparin vs Aspirin vs Low-Dose Warfarin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Thalidomide Based-Regimens.

Prognostic impact of c-KIT mutations in core binding factor leukemias: an Italian retrospective study

Serum Concentrations of Vitamin B-12 and Alkaline Phosphatase in Newly Diagnosed Multiple Myeloma Patients.

Acquired Resistance to Activated Protein C (aAPCR) Is Associated with Increased Risk of Deep Vein Thrombosis in Multiple Myeloma.

The Anti-Myeloma Effect of Bortezomib Is Associated with Osteoblastic Activity.

Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.

Prognostic Impact of C-Kit Mutations in Core Binding Factor-Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only